» Download Public Reports
About 200 reports
- Country report
- February 2013
- 2 pages
... This pragmatic approach would, we believe, ensure the supply of medicines for patients up and down the uk, at a critical time. Speaking at the bapw spring business day in birmingham, mr sawer ...
December 2012
... Exhibit 4 antibacterial, anaesthetic, analgesics, vitamins and speciality pharmaceutical products intravenous fluids licensed veterinary aqupharm market leading range of intravenous solutions in the uk ...
March 2013
... In revenues last year, and earned $177.5 Million in net income. Its cro division generated 74% of its revenues. Also noted: quintiles helped develop or commercialize 85% of the central nervous system drugs ...
October 2012
... Are supplied over the internet 10 Instances of counterfeit medicines in the legitimate supply chain that reached pharmacies and led to recall since 2004 850 Million+ prescriptions written ...
October 2012
... Consolidation and review of uk medicines legislation 2.2 The mhra has been undertaking an exercise to, as far as practicable, bring together all uk medicines legislation into a single consold text ...
November 2012
... Original written evidence, we presented our own research which tracked the progress of smc approved medicines onto local nhs board formularies. We have included as an appendix an update of original ...
April 2013
... Antiretroviral therapy; ci, confidence interval, efv, efavirenz; ftc, emtricitabine; str, single tablet regimen; tdf, tenofovir disoproxil fumarate. Total costs comprised inpatient days, outpatient and dayward ...
October 2012
... In the context of this programme, Quality assured Is defined as a medicine that is: approved by a stringent drug regulatory authority (sra); prequalified under the who prequalification programme ...
» Purchase Premium Reports
(From $ 613 - $ 4 995)
About 100 reports
- $ 4 995
- Industry report
- February 2013
- by Global Data
PharmaPoint: Osteoporosis - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Osteoporosis - UK Drug Forecast and Market Analysis to 2022?. ...
May 2013
$ 5 174
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...
March 2013
$ 3 995
PharmaFocus: Vaccine Adjuvants in Infectious Disease Summary Originally discovered by Glenny in the 1920s, vaccine adjuvants have remained the pharmaceutical industry's ?dirty little secret?. Today, ...
April 2013
$ 1 088
Includes 3 FREE quarterly updates BMI View: While the strength of the UK's pharmaceutical manufacturing market is significant, the segment will face considerable challenges over the coming years. Economic ...
May 2013
$ 652
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in United Kingdom. The study provides essential market information for decision-makers ...